Chembio Diagnostics DSO Ratio 2011-2026 | CEMI

Annual DSO Ratio Chembio Diagnostics

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
66.3	56.6	39.6	58.4	49.9	41.6	59.3	81	85.4	58.1	55.7	65.4	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
85.4	39.6	59.8

Quarterly DSO Ratio Chembio Diagnostics

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	38.7	70.4	51.7	-	36.9	38.1	30.3	-	27.2	66.8	56.8	-	61.5	73.5	83	-	71.4	56	34.9	59.8	62.8	115	65.4	81.4	107	132	50.6	123	122	116	122	-	85.7	54	62.5	-	44.6	77.6	69	-	43.6	43.7	45.4	-	12.7 K	20.8 K	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
20.8 K	27.2	946

DSO Ratio of other stocks in the Diagnostics research industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	145	-	-6.23 %	$ 30.6 M	Germany
Heska Corporation HSKA	40.8	-	-	$ 1.31 B	USA
Agilent Technologies A	63.8	$ 135.53	0.11 %	$ 41.2 B	USA
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
Co-Diagnostics CODX	94.7	$ 8.53	-23.77 %	$ 11.3 M	USA
Castle Biosciences CSTL	50.2	$ 21.08	-4.66 %	$ 611 M	USA
Aspira Women's Health AWH	1.17 K	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	72.7	-	-61.36 %	$ 2.46 M	USA
Fulgent Genetics FLGT	87	$ 18.14	-0.55 %	$ 558 M	USA
Biocept BIOC	112	-	-13.05 %	$ 7.29 M	USA
Guardant Health GH	46.1	$ 129.69	-2.65 %	$ 16.3 B	USA
Oxford Immunotec Global PLC OXFD	90.8	-	-	$ 562 M	Britain
CareDx, Inc CDNA	51.5	$ 22.82	0.53 %	$ 1.22 B	USA
ICON Public Limited Company ICLR	63.4	$ 136.07	-0.53 %	$ 10.7 B	Irlanda
Interpace Biosciences IDXG	66.9	$ 1.7	-5.56 %	$ 7.52 M	USA
HTG Molecular Diagnostics HTGM	101	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	61.3	$ 162.96	2.68 %	$ 25.9 B	USA
Lantheus Holdings LNTH	80.5	$ 99.3	-0.32 %	$ 6.7 B	USA
Global Cord Blood Corporation CO	112	-	-	$ 399 M	China
Fluidigm Corporation FLDM	67.2	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	11.7 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	122	-	0.12 %	$ 80.1 M	China
DermTech DMTK	80.6	-	-11.32 %	$ 2.94 M	USA
Mettler-Toledo International MTD	66.4	$ 1 180.58	1.47 %	$ 24.3 B	Schweiz
Charles River Laboratories International CRL	65	$ 180.71	-0.35 %	$ 8.96 B	USA
NeoGenomics NEO	77.7	$ 10.52	3.24 %	$ 1.35 B	USA
PRA Health Sciences, Inc. PRAH	98.1	-	-	$ 10.7 B	USA
Enzo Biochem ENZ	50.3	-	-8.98 %	$ 14.8 K	USA
National Research Corporation NRC	29.4	$ 19.53	-0.66 %	$ 437 M	USA
Natera NTRA	81.5	$ 223.37	4.41 %	$ 22 B	USA
Medpace Holdings MEDP	50.4	$ 447.11	-0.23 %	$ 12.9 B	USA
Exact Sciences Corporation EXAS	30.8	-	-	$ 19.8 B	USA
Myriad Genetics MYGN	52.3	$ 3.97	-5.92 %	$ 368 M	USA
Personalis PSNL	63.8	$ 11.4	3.83 %	$ 1.02 B	USA
Senseonics Holdings SENS	1.04	$ 6.79	1.04 %	$ 283 M	USA
QIAGEN N.V. QGEN	30.8	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	27	-	-	$ 2.69 B	USA
Twist Bioscience Corporation TWST	44.5	$ 66.87	-3.13 %	$ 4 B	USA
Biomerica BMRA	57.7	$ 2.39	-1.74 %	$ 5.49 M	USA
Laboratory Corporation of America Holdings LH	52.9	$ 260.06	-0.75 %	$ 21.6 B	USA
Thermo Fisher Scientific TMO	70	$ 492.51	1.09 %	$ 186 B	USA
Trinity Biotech plc TRIB	87.2	$ 0.7	-0.16 %	$ 251 M	Irlanda
Motus GI Holdings MOTS	77.2	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	66.6	$ 8.97	-3.55 %	$ 1.95 B	USA
Quest Diagnostics Incorporated DGX	44.9	$ 194.9	-0.72 %	$ 21.6 B	USA
Invitae Corporation NVTA	242	-	-	$ 21.2 M	USA